MBX Biosciences, Inc. (MBX)
Healthcare
Biotechnology
65.90 $
-0.8%
vs. previous close
Closing price · As of: 31. Jul 2026
MBX Biosciences, Inc. (MBX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -80 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| -23 | -32 | -55 | -80 | |
| 0.1 | 0.2 | 0.2 | -3.6 | |
| 0.3 | 2.0 | 5.2 | 8.7 | |
| 1.3 | -0.7 | 4.6 | 1.6 | |
| 0.4 | 0.1 | 0.9 | 1.9 | |
| -11 | -31 | -161 | -84 | |
| 10 | 0.0 | – | – | |
| 46 | 69 | 234 | 190 | |
| 12 | 6.3 | 19 | 26 | |
| -24 | -32 | -56 | -82 |
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.